Han, Edward X.
Qian, Hong
Jiang, Bo
Figetakis, Maria
Kosyakova, Natalia http://orcid.org/0000-0002-8213-8438
Tellides, George
Niklason, Laura E.
Chang, William G. http://orcid.org/0000-0002-7707-9242
Funding for this research was provided by:
Humacyte, Inc
Article History
Received: 3 February 2021
Accepted: 7 July 2021
First Online: 29 July 2021
Competing interests
: L.E.N. is a founder, CEO, and shareholder in Humacyte, Inc., which is a regenerative medicine company. Humacyte produces engineered blood vessels from allogeneic smooth muscle cells for vascular surgery. L.E.N.’s spouse has equity in Humacyte, and L.E.N. serves on Humacyte’s Board of Directors. L.E.N. is an inventor on patents that are licensed to Humacyte and that produce royalties for L.E.N. L.E.N. has received an unrestricted research gift to support research in her laboratory at Yale. The remaining authors declare no competing interests.